Login / Signup

Anti-protein phosphatase magnesium-dependent 1A-IgM levels in patients with active ankylosing spondylitis: a potential biomarker.

Yeo-Jin LeeEun-Ju LeeSoo Min AhnSeokchan HongJi Seon OhChang-Keun LeeBin YooYong-Gil Kim
Published in: Advances in rheumatology (London, England) (2024)
Decreased anti-PPM1A-IgM levels in AS patients suggests a potential role for anti-PPM1A-IgM in the diagnosis of active AS.
Keyphrases
  • ankylosing spondylitis
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • rheumatoid arthritis
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • binding protein
  • amino acid